Boston Scientific Corporation (ETR:BSX)

Germany flag Germany · Delayed Price · Currency is EUR
87.60
-0.40 (-0.45%)
At close: Jun 24, 2025, 5:30 PM CET
22.52%
Market Cap 132.46B
Revenue (ttm) 16.24B
Net Income (ttm) 1.88B
Shares Out n/a
EPS (ttm) 1.27
PE Ratio 70.46
Forward PE 35.04
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 240
Open 88.80
Previous Close 88.00
Day's Range 87.60 - 88.80
52-Week Range 62.00 - 105.00
Beta n/a
RSI 46.56
Earnings Date Jul 23, 2025

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1979
Employees 53,000
Stock Exchange Deutsche Börse Xetra
Ticker Symbol BSX
Full Company Profile

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD Financial Statements

News

I'm Buying Dividend Aristocrats At Bargain Basement Prices

Now is an opportune time to focus on income stocks like that offer value and stability amid market volatility. I focus on 2 Dividend Aristocrats that are attractively valued while supporting well-cove...

7 days ago - Seeking Alpha

S&P 500 Surges 1%; New York Manufacturing Activity Tumbles In June

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 1% on Monday. The Dow traded up 0.80% to 42,536.72 while the NASDAQ climbed 1.51% to 19,699.21. The S&P 500 also rose,...

8 days ago - Benzinga

What's Happening With Boston Scientific Stock?

Boston Scientific (NYSE:BSX) has experienced a stock price increase of over 30% in the last twelve months, greatly exceeding the S&P 500's gain of 9%. This remarkable performance can be credited to th...

8 days ago - Forbes

US Stocks Higher; Dow Jumps Over 400 Points

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 400 points on Monday. Following the market opening Monday, the Dow traded up 1.02% to 42,629.20 while the NASDAQ clim...

8 days ago - Benzinga

This Boston Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...

8 days ago - Benzinga

$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today

Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 7.78% on an annualized basis producing an average annual return of 18.87%. Currently, Boston Scientific has a marke...

12 days ago - Benzinga

20 stocks bucking bad trends on Wall Street — what might be next for them?

Analysts have been cutting their estimates for companies' sales and profits, but there are always exceptions to trends.

14 days ago - Market Watch

3 Growth Stocks That Aren't the Magnificent 7

Growth-oriented investors have been able to operate on autopilot, but tomorrow's winners might not look like yesterday's.

18 days ago - Barrons

Is Boston Scientific Gaining or Losing Market Support?

Boston Scientific's (NYSE: BSX) short percent of float has risen 6.6% since its last report. The company recently reported that it has 16.75 million shares sold short , which is 1.13% of all regular ...

20 days ago - Benzinga

P/E Ratio Insights for Boston Scientific

In the current market session, Boston Scientific Inc. (NYSE: BSX) stock price is at $104.20, after a 0.29% drop. However, over the past month, the company's stock increased by 0.10% , and in the past...

25 days ago - Benzinga

Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire

Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted.

26 days ago - Investor's Business Daily

Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook

Boston Scientific Corporation (NYSE: BSX) is pulling the plug on its ACURATE neo2 and Prime aortic valve systems . What Happened : The medical technology giant halted global sales and abandoned regul...

27 days ago - Benzinga

Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook

Boston Scientific Corporation BSX is pulling the plug on its ACURATE neo2 and Prime aortic valve systems.

27 days ago - Benzinga

How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott

Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.

27 days ago - Investor's Business Daily

Boston Scientific to not seek US approval for heart device amid regulatory challenges

Boston Scientific said on Wednesday it will stop pursuing U.S. approval for its experimental heart device due to increased clinical and regulatory requirements.

27 days ago - Reuters

$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today

Boston Scientific (NYSE: BSX) has outperformed the market over the past 15 years by 8.95% on an annualized basis producing an average annual return of 21.03%. Currently, Boston Scientific has a marke...

5 weeks ago - Benzinga

Boston Scientific Stock Flirts With A Buy Point, Once Again

Boston Scientific stock is wavering around the buy point of a double-bottom base. The company recently raised its 2025 earnings outlook.

6 weeks ago - Investor's Business Daily

$100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today

Boston Scientific (NYSE: BSX) has outperformed the market over the past 15 years by 8.98% on an annualized basis producing an average annual return of 20.36%. Currently, Boston Scientific has a marke...

7 weeks ago - Benzinga

Boston Scientific announces upcoming investor conference schedule

MARLBOROUGH, Mass. , May 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May.

7 weeks ago - PRNewsWire

Baron Health Care Fund Q1 2025 Top Contributors And Detractors

Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals sa...

2 months ago - Seeking Alpha

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

Trial achieves positive results in the treatment of persistent atrial fibrillation MARLBOROUGH, Mass. and SAN DIEGO , April 24, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today ann...

2 months ago - PRNewsWire